CDIO
NASDAQ · Biotechnology
Cardio Diagnostics Holdings
$1.97
+0.09 (+4.52%)
Financial Highlights (FY 2026)
Revenue
25.2K
Net Income
-10,980,222
Gross Margin
—
Profit Margin
-43,817.7%
Rev Growth
—
D/E Ratio
0.04
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | — | 58.2% | 58.2% | 58.2% |
| Operating Margin | -43,722.7% | -26.4% | -27.2% | -29.6% |
| Profit Margin | -43,817.7% | -27.7% | -27.4% | -29.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 25.2K | 758.5K | 743.9K | 754.7K |
| Gross Profit | — | 441.1K | 432.6K | 438.9K |
| Operating Income | -10,998,435 | -200,597 | -202,242 | -223,204 |
| Net Income | -10,980,222 | -209,998 | -203,473 | -219,048 |
| Gross Margin | — | 58.2% | 58.2% | 58.2% |
| Operating Margin | -43,722.7% | -26.4% | -27.2% | -29.6% |
| Profit Margin | -43,817.7% | -27.7% | -27.4% | -29.0% |
| Rev Growth | — | -7.2% | +1.3% | +15.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 103.6K | 1.13M | 951.2K | 921.9K |
| Total Equity | 2.68M | 1.55M | 1.63M | 1.54M |
| D/E Ratio | 0.04 | 0.72 | 0.58 | 0.60 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -10,846,158 | -263,366 | -243,311 | -249,018 |
| Free Cash Flow | — | -217,938 | -231,433 | -197,267 |